Journal article 322 views 52 downloads
A web-based intervention (RESTORE) to support self-management of cancer-related fatigue following primary cancer treatment: a multi-centre proof of concept randomised controlled trial / Deborah, Fenlon
Supportive Care in Cancer, Volume: 24, Issue: 6, Pages: 2445 - 2453
Swansea University Author: Deborah, Fenlon
PDF | Accepted ManuscriptDownload (435.54KB)
Purpose Cancer-related fatigue (CRF) is a frequent anddistressing symptom experienced after cancer treatment.RESTORE is the first web-based resource designed to enhanceself-efficacy to manage CRF following curative-intenttreatment. The aim of this study is to test the proof of conceptand inform the...
|Published in:||Supportive Care in Cancer|
Check full text
No Tags, Be the first to tag this record!
Purpose Cancer-related fatigue (CRF) is a frequent anddistressing symptom experienced after cancer treatment.RESTORE is the first web-based resource designed to enhanceself-efficacy to manage CRF following curative-intenttreatment. The aim of this study is to test the proof of conceptand inform the design of an effectiveness trial.Methods A multi-centre parallel-group two-armed (1:1) exploratoryrandomised controlled trial (RCT) with qualitativeprocess evaluation was employed in the study. Participants(≥18 years; ≤5 years post treatment with moderate to severefatigue) were recruited and randomly assigned to RESTOREor a leaflet. Feasibility and acceptability were measured byrecruitment, attrition, intervention adherence, completion ofoutcome measures and process evaluation. Change in selfefficacyto manage CRF was also explored. Outcome measureswere completed at baseline (T0), 6 weeks (T1) and12 weeks (T2). Data were analysed using mixed-effects linearregression and directed content analysis.Results One hundred and sixty-three people participated inthe trial and 19 in the process evaluation. The interventionwas feasible (39 % of eligible patients consented) and acceptable(attrition rate 36 %). There was evidence of higher fatigueself-efficacy at T1 in the intervention group vs comparator(mean difference 0.51 [−0.08 to 1.11]), though the differencein groups decreased by 12 weeks. Time since diagnosis influencedperceived usefulness of the intervention. Modificationswere suggested.Conclusion Proof of concept was achieved. The RESTOREintervention should be subject to a definitive trial with some adjustments.Provision of an effective supportive resource would empower cancersurvivors to manage CRF after treatment completion.
College of Human and Health Sciences